Despite the threat of terrorism, it is important that the famhp continues to guarantee its services as a federal institution and to exert its mission with even more professionalism.
As a precautionary measure, the staff of the famhp received the recommendation to telework as much as possible and to avoid coming to Brussels. The meetings are reduced to a bare minimum.
The famhp staff can best be contacted by e-mail.
The situation will be monitored very closely and we will update you once we have relevant information.
Thanks in advance for your understanding.
Xavier De Cuyper
The famhp has new phone numbers.
Since October 1, 2015 the famhp has new phone numbers. From now on you can contact us at this phone number : + 32 2 528 40 00 (reception).
If you want to contact directly a colleague, you can do it by dialling figures + 32 2 528 4x xx instead of + 32 2 524 8x xx. The last three figures remain the same.
The famhp promotes the use of e-mail. This way we can better follow all questions and answer them more in detail. Consult the list of the different contact points within the agency.
Les médicaments génériques sont aussi de qualité, sûrs et efficaces.
The famhp is actively involved in the management of the Ebola dossier:
Read more on the role of the famhp.
More information on:
Information for the public
December 20 and 22, 2015 : final dates for submitting dossiers « Marketing Authorisation/ Registration » and « « Research & Development »
As the famhp will be closed from Christmas to the New Year, we advise you to foresee December 20, 2015 as the final date on the one hand for submitting requests for new marketing authorisations, variations, renewals and requests for parallel importation for medicines for human use or veterinary use, on the other hand to foresee December 22, 2015 as the final date for the submissions introduced to the Division “Research & Development”. The validation of dossiers submitted after this date will only start on January 4, 2016.read more
The famhp has updated the e-Submission guidelines in order to underline the required use of the electronic application form starting from the 1st of January 2016.read more
To the attention of the holders of Mas for medicinal products for human use : update of the document ‘New definition of the approval date in SmPC and leaflet’
The document ‘New definition of the approval date in SmPC and leaflet’ was recently subject to adjustments.read more
Links to pages and documents useful for healthcare professionals
- Direct Healthcare Professional
- Field Safety Notices concerning
- Therapeutic Magistral Form (TMF)
- Unavailability of medicinal products
- RMA-materials (Risk Minimisation Activities)
- International Nonproprietary Name (INN) prescription and substitution
- Withdrawal periods (medicines for veterinary use)